Despite the previously studies have observed the elevated serum levels of BAFF in DM patients, to the best of our knowledge, the relationship between serum BAFF levels and RP-ILD development in anti-MDA5+DM has never been reported. Here, IFIH1 is linked to dermatomyositis.